Peptides in Skincare: The Ingredient List Decoded

By BioLabs Research · October 4, 2026 · 5 min read

"Palmitoyl pentapeptide-4." "Acetyl hexapeptide-8." "Copper tripeptide-1." Here is what those words on the back of the bottle actually mean.

Why everyone is suddenly talking about peptides

Peptides have been studied as skincare ingredients since at least the early 2000s (see the studies below), but 2026 is the year they went mainstream. Glossy, citing Spate market research, reported that interest in "peptide therapy" rose 281% on Google, 459% on TikTok and 412% on Instagram year over year as of early April 2026. It also described a wave of new peptide product launches across beauty (Glossy).

That much attention brings a lot of marketing language, so it helps to start with the basics.

What a peptide is

A peptide is a short chain of amino acids, the same building blocks that make up proteins. Proteins like collagen are long chains. Peptides are short ones, sometimes just two to ten amino acids.

ELLE quotes a dermatologist describing peptides as molecules that "play a key role in communication between cells" (ELLE). That messenger idea explains most of how the industry markets them.

The four families you'll see in marketing

A 2009 review from the University of California, San Francisco dermatology department sorted topical cosmetic peptides into four groups: signal peptides, enzyme-inhibitor peptides, neurotransmitter-inhibitor peptides and carrier peptides (Gorouhi & Maibach, International Journal of Cosmetic Science, 2009). Brands still use these categories.

1. Signal peptides: "make more collagen"

The pitch: these peptides tell skin cells to produce more structural proteins such as collagen.

The best-known example: palmitoyl pentapeptide (pal-KTTKS), often sold under the trade name Matrixyl and now commonly listed as palmitoyl pentapeptide-4.

What research shows: a 12-week, double-blind, placebo-controlled split-face study in 93 women aged 35 to 55 reported a significant reduction in wrinkles and fine lines compared with the same moisturizer without the peptide (Robinson et al., Int. J. Cosmet. Sci., 2005). That is a real controlled trial. Note, though, that the authors were from Procter & Gamble's research labs, the trial was 12 weeks long, and all participants were Caucasian women. It is a starting point, not the final word.

2. Carrier peptides: "deliver something useful"

The pitch: these peptides carry a trace element, usually copper, into the skin.

The best-known example: copper tripeptide-1, also called GHK-Cu.

What research shows: a large body of cell, tissue and animal research, much of it reviewed by the molecule's discoverer (Pickart et al., BioMed Research International, 2015), plus smaller cosmetic trials. NPR described those trials as generally small and industry-funded (NPR, 2026). Marie Claire notes that on a label you will often see it as "Copper Tripeptide-1" or "GHK-Cu" (Marie Claire).

3. Neurotransmitter-style peptides: the "topical Botox" claim

The pitch: these peptides are said to reduce the muscle signals behind expression lines.

The best-known example: acetyl hexapeptide-3 (Ac-EEMQRR-NH2), sold under the trade name Argireline.

What research shows: the 2002 paper that introduced it reported that, in lab tests, the peptide interfered with the protein machinery nerves use to release signals, and that a cream containing it reduced wrinkle depth in a small group of volunteers over 30 days (Blanes-Mira et al., Int. J. Cosmet. Sci., 2002). The same paper says it showed "much lower efficacy" than botulinum toxin. Treat the "Botox in a jar" headlines with that in mind.

4. Enzyme-inhibitor peptides: "protect what you have"

The pitch: these slow the enzymes that break down existing collagen. Marie Claire describes them as peptides that "slow the breakdown of collagen you already have" and notes that soy-derived peptides often fall here (Marie Claire).

What research shows: our source check for this draft did not turn up large, independent clinical trials for this group, so treat its claims with extra caution. The 2009 review covers it alongside the other three families (Gorouhi & Maibach, 2009).

How to read a cosmetic label

Cosmetic ingredient lists use standardized names, often called INCI names. That is why you see "palmitoyl tripeptide-1" instead of a brand name. Under US rules, cosmetic ingredients are generally listed in descending order of predominance (21 CFR 701.3).

A few practical reading tips:

• Position matters, roughly. An ingredient near the end of a long list is usually present in a small amount. Some peptides are tested at very low concentrations (the Robinson trial used 3 parts per million), so a late position doesn't necessarily mean the ingredient is pointless.
• The label won't tell you the percentage. Most labels don't state how much peptide is in the product, so you can't compare it directly with a published study.
• Trade names are not ingredients. "Matrixyl" or "Argireline" are supplier trade names. The INCI name is what appears on the label.
• Claims tell you the category. FDA says a product's legal category depends on its intended use. Claims to "restore hair growth" or "regenerate cells," for example, can make a product a drug even if it is marketed as a cosmetic (FDA: Is It a Cosmetic, a Drug, or Both?).

How a research catalog is different

A research catalog answers a different question. A cosmetic label asks what is in the product and in what order. A research listing asks what the compound is, how pure it is, and how that was verified.

That is why research listings rely on documents like a certificate of analysis (COA), with HPLC purity and mass-spectrometry identity data. Research materials are characterized compounds for laboratory work. They are not drugs or supplements, and they are not cosmetics, so the two kinds of labels aren't interchangeable.

What we know / What we don't know

What we know

• Cosmetic peptides are usually grouped into signal, carrier, neurotransmitter-inhibitor and enzyme-inhibitor families (Gorouhi & Maibach, 2009).
• At least some peptides, such as pal-KTTKS, have placebo-controlled cosmetic trials behind them (Robinson et al., 2005).
• Many trials are small, short and run or funded by industry (NPR, 2026; Harvard Health).

What we don't know

• How well the results of individual ingredient studies carry over to finished products, which combine many ingredients at unknown concentrations.
• Long-term comparisons between peptide types in large, independent trials.

For researchers: how we document compounds

If you want to understand the lab side, our COA verification guide on HPLC purity and mass-spectrometry identity explains how to read the documents that come with research materials. For research use only.

Related reading: What 'Research Use Only' Means: Labels, Limits and Lab Supply

---

Sources are linked inline. This article is for general information. It is not medical advice. BioLabs Research supplies research materials, not drugs or supplements, for laboratory research use only.

For research use only. Not for human or veterinary use. Not a drug, food, or cosmetic.

This summary is for research-community awareness only and is not legal advice.